1. PPXRD-2 Pharmaceutical Powder X-ray Diffraction Symposium December 9-12, 2002

2. PPXRD-2 Hotel in Philadelphia area Similar in format to PPXRD-1, held in 1999 Goals: – to promote ICDD’s new organic product, the ICDD/CCDC collaborative product – to capture the Rx market

3. Program Committee Dr. John Faber, Chair, ICDD Dr. Thomas Blanton, Eastman Kodak Company Prof. Noriaki Hirayama, Tokai University Dr. Arnt Kern, Bruker AXS GmbH Prof. Daniel Louer, Universite de Rennes 1 Dr. Stephen J. Maginn, Cambridge Crystallographic Data Centre Dr. Fangling Needham, International Centre for Diffraction Data Prof. Peter W. Stephens, State University of New York Dr. Gregory A. Stephenson, Eli Lilly and Company Dr. Peter G. Varlashkin, GlaxoSmithKline

4. Program Format: 3 days of technical talks + 1-day optional workshop Technical Program Acquisition & Use of X-ray Powder Diffraction Data Indexing Polymorph Characterization by XRPD Structure Determination & Molecular Modeling Regulatory & Patent Issues Optional Workshop – Topics TBD Structure Determination from Powders, Indexing, Alignment and Configuration, Rietveld Analysis

5. Abstracts Deadline for abstracts is August 1, 2002 Guidelines can be found on our web page

6. Monday Evening Events Poster session Tabletop exhibits -also on display all day Monday and half day Tuesday Mixer Attention Vendors... Sponsorships and advertising opportunities are available!

7. Stay Informed... Visit www.icdd.com/ppxrd for current information Add your name to our PPXRD mailing list Talk to a Program Committee member or ICDD staff member